PNC vs STRO · P/E 14, rev $23.10B vs rev $62.0M
PNC Financial Services Group Inc (PNC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PNC revenue for 2025-12-31 was $23.10B. Net income was $7.00B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PNC currently screens at market cap $77.76B and trailing P/E 13.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PNC and STRO stock pages for the full models.
Not investment advice.